6505--XOFIGO (Radium Ra-223) 36C25626Q0501
Summary
AI-generated · Mar 13, 2026MEDVAMC Houston is seeking information on XOFIGO Isotope (Radium Ra-223) to determine how it will procure this 6 mL injectable product in support of an upcoming solicitation. This market-research RFI will help define the procurement approach (e.g., small-business set-aside, sole source, or unrestricted) and informs the attached Draft Statement of Work; no contract will be awarded from this notice itself.
Respondents should indicate whether the item is manufactured by their firm, their business size and any applicable certifications, compliance with the Non-Manufacturer Rule, and whether they are an authorized OEM distributor (with OEM-verified authorization). Provide the name and contact information of a capable contractor, proof of business size and identifiers, and whether the firm participates under Government-wide contracts (GWACs, GSA/FSS/IDIQ/BPA). Also supply an estimated market price for planning purposes and any documentation demonstrating NMR compliance and OEM authorization. This information is for market research only to help MEDVAMC decide the procurement strategy; there is no solicitation at this time.
This is a source sought notice/request for information only. The responses to this posting will be used to establish the procurement strategy, for example, set-aside, sole source, unrestricted for a solicitation that VA intends to post in the near future. Please review the attached document(s) for more details on this requirement. See attached document(s): -36C25626Q0501 - Request for Information (RFI) -Statement of Work (SOW) DISCLAIMER: THIS IS A SOURCES SOUGHT NOTICE ONLY. THIS SYNOPSIS IS NOT A REQUEST FOR QUOTE, PROPOSAL, OR BID. This notice is not a solicitation as defined by FAR 2.101, therefore it shall not be construed as a commitment by the government to enter into a contract, nor does it restrict the government to an acquisition approach. All information contained in this Request for Information (RFI) is preliminary as well as subject to amendment and is in no way binding on the government. Information submitted in response to this notice is voluntary; the government will not pay for information requested nor will it compensate any respondent for any cost incurred in developing information provided to the government. The government is requesting that restrictive or proprietary markings not be used in response to this notice. If a solicitation is released, it will be synopsized in the Federal Contract Opportunities website or General Services Administration (GSA). It is the responsibility of the interested parties to monitor these sites for additional information pertaining to this RFI. 1. Title: XOFIGO Isotope (Radium Ra-223) 2. Purpose: The purpose of this RFI is to identify potential sources that will aid in defining the procurement strategy for example, set-aside, sole source, or unrestricted for a solicitation the VA intends on issuing shortly as follows: The Michael E. DeBakey VA Medical Center (MEDVAMC) located in Houston, Texas has a requirement for XOFIGO Isotope (Radium Ra-223), items listed below: Item# Description/Part Number* Products QTY 1. 6ML RADIUM RA 223DICHLORIDE INJ XOFIGO 1 JB The anticipated Small Business Administration (SBA) size standard for the North American Industry Classification System (NAICS) code is 325412 Pharmaceutical Preparation Manufacturing and a standard size of $19.0M. Product Supply Code (PSC) 6505 Drugs and Biologicals. 3. Responses Requested: The following questions must be answered in response to this RFI. Answers that are not provided shall be considered non-responsive to the RFI: a. Are the requested items manufactured by a small or large business? Vendor must attach documentation of this information to be viewed by the government to be considered as part of Market Research and responsiveness to this Sources Sought notice: b. Is the potential vendor in compliance with the Non-Manufacturer Rule (NMR)? Vendor must attach documentation of this to be viewed by the government to be considered as part of the Market Research and responsiveness to this Sources Sought notice: c. Is the Vendor an authorized distributor with access to Original Equipment Manufacturer (OEM) parts which may be required in completion of this requirement? The VA does not accept grey market items; therefore, the Vendor must attach an authorized distribution letter as an approved and authorized vendor on OEM letterhead by the manufacturer as evidence of proof to be viewed by the government to be considered as part of the Market Research and responsiveness to this Sources Sought notice. d. Name of potential Contractor that possesses the capability to fulfill this requirement. Contractors shall also provide the following: Point(s) of contact name: ______________________________________ Address: ___________________________________________________ Telephone number: ___________________________________________ Email address: _______________________________________________ Company's business size: _______________________________________ UEI #: ______________________________ CAGE Code: _______________________________ e. Is your company considered a small business concern, SB, SDVOSB, VOSB, HUBZone, or 8A concern, with the requisite 325412 NAICS code? Please provide proof of qualifications. f. Is your company available under any Government Wide Agency Contract (GWAC), GSA Schedule, Federal Supply Schedule (FSS), Indefinite Delivery Indefinite Quantity (IDIQ), and/or Blanket Purchase Agreement (BPA)? If so, please identify the contract number for the government to review as part of this Market Research. 4. Opportunity/Market Pricing: MEDVAMC is seeking information from potential vendors on their ability to provide the required items/equipment. THIS IS A SOURCES SOUGHT REQUEST FOR INFORMATION (RFI) ONLY. Small Business concerns are encouraged to provide responses to this RFI in order to assist the MEDVAMC in determining potential levels of competition and general market pricing available in the industry. Vendors are requested to submit estimated market research pricing along with their responses to the above. The estimated pricing will be considered when determining the procurement strategy for the forthcoming solicitation. Contractor shall provide answers to all questions requested and shall possess the ability to provide all requirements and objectives per the DRAFT STATEMENT OF WORK. 5. RFI responses are due by 15:00 pm Central Standard Time on March 17, 2026; size is limited to 8.5 x 11 inches, 12-point font, with 1-inch margins in Microsoft Word format via email to frank.sanders1@va.gov The subject line shall read: RFI 36C25626Q0501- XOFIGO Isotope (Radium Ra-223) NO SOLICITATION EXISTS AT THIS TIME. There is no page limitation on subparagraphs 3(a) - 3(g). Please provide the information you deem relevant in order to respond to the specific inquiries of the RFI. Information provided will be used solely by MEDVAMC as Market Research and will not be released outside of the MEDVAMC Purchasing and Contracting Team. 6. Contact Information: Frank Sanders frank.sanders1@va.gov See attached document: Statement of Work - Xofigo (Radium Ra-223).
From Sources Sought posted on Mar 12, 2026Notice history
1-
Sources Sought LATEST Posted Mar 12, 2026
Details
Award Information
Contacts
Contract Specialist
Phone
Agency
Place of Performance
Houston, Texas
77030
USA